Skip to main content

Jacques Planas Morin

Institutions of which they are part

Biomedical Research in Urology
Vall Hebron Institut de Recerca

Jacques Planas Morin

Institutions of which they are part

Biomedical Research in Urology
Vall Hebron Institut de Recerca

Projects

Detección temprana de recurrencia para una terapia personalizada en pacientes hormono-sensibles con cáncer de próstata metastásico.

IP: -
Collaborators: Luisa Maria Martinez Sánchez, Maria Eugenia Semidey Raven, Jacques Planas Morin
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 108900
Reference: RTI2018-096055-B-I00
Duration: 01/01/2019 - 30/09/2022

El estrés terapeútico como generador de resistencia en las células madre neoplásicas prostáticas: marcadores predictivos de resistencia y dianas terapéuticas

IP: -
Collaborators: Inés de Torres Ramirez, Jacques Planas Morin
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 181500
Reference: SAF2014-59958-R
Duration: 01/01/2015 - 31/12/2017

Unitat de Recerca Biomèdica i Oncologia Translacional (GRC)

IP: Jaume Reventós Puigjaner
Collaborators: José Placer Santos, Joan Morote Robles, Maria Asuncion Perez Benavente, Eva Colas Ortega, Berta Diaz Feijoo, Silvia Cabrera Diaz, Antonio Gil Moreno, Marina Rigau Resina, Jacques Planas Morin
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 50000
Reference: 2014 SGR 1330
Duration: 01/01/2014 - 31/12/2016

Perfiles de MicroRNA como biomarcadores predictivos del cáncer de próstata agresivo para la optimización de las decisiones terapéuticas

IP: Joan Morote Robles
Collaborators: Inés de Torres Ramirez, Alex Sánchez Pla, Jacques Planas Morin
Funding agency: Instituto de Salud Carlos III
Funding: 57475
Reference: PI13/00173
Duration: 01/01/2014 - 30/06/2018

Related news

On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.

The work led by Dr. Regis demonstrates that performing robotic reconstruction after radical prostatectomy is associated with better urinary control.

A clinical trial with the prototype of the device shows that the use of this technology improves patient monitoring by nurses and reduces post-surgical complications.

Related professionals

David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more
SILVIA GARTNER TIZZANO

SILVIA GARTNER TIZZANO

Main researcher
Growth and Development
Read more
Luca Basile

Luca Basile

Administration and Management
Microbiology
Read more
Ana  Leon  Espitia

Ana Leon Espitia

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.